Radiology AI vendor Bot Image may market its prostate software not only for diagnosing cancer when suspected but also for performing prostate screenings.

Big Tech players have been investing in partnerships with large healthcare providers on AI endeavors for several years now. According to both sides in one such collaboration, the resulting synergy offers “immense potential” to improve patient access, care and outcomes.

The move comes as RSV has been on the rise in the United States.

UnitedHealthcare announced it would remove 20% of its current prior authorizations starting with the third quarter of this year. 

The emerging fungus, Candida auris (C. auris), has been spreading across healthcare facilities at an “alarming rate,” according to the CDC.

Federal investigations that began in 2019 into Amazon’s potential abuse of power and consumer privacy violations may soon come to fruition with lawsuits to block the company's monopoly status, Politico reported. 

The FDA has OK’d a new artificial intelligence platform for quickly diagnosing stroke on unenhanced CT scans.

One of the 10 largest banks in the country is marketing a new AI-based system aimed at flagging upcoming medical claims that are likely to court rejection by payers.